HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
3 hedge funds and large institutions have $3.38M invested in Hepion Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$249K |
| 2 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$186K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$120K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$31K |
| 5 |
Bank of New York Mellon
New York
|
-$30K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SBL
26
Sargent Bickham Lagudis
Boulder,
Colorado
| $1 | -$1K | – | – |
|
27
UBS Group
Zurich,
Switzerland
| – | -$5K | – | – |
|
|
EWA
28
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
| – | -$10K | – | – |
|
29
Nomura Holdings
Tokyo,
Japan
| – | -$17K | – | – |
|